Pomerantz Law Firm Probes Potential Investor Claims Against Nyxoah S.A. Following Stock Decline
Pomerantz Law Firm Investigation into Nyxoah S.A. Claims
New York, April 28, 2025 – In an important update for investors in Nyxoah S.A. (NASDAQ: NYXH), the Pomerantz Law Firm has commenced an investigation into potential legal claims arising from recent events concerning the company. The inquiry focuses on whether Nyxoah, alongside some of its officers and directors, engaged in practices that could be classified as securities fraud or other unlawful business operations.
On March 25, 2025, Nyxoah made headlines with a brief press release detailing that the U.S. Food and Drug Administration (FDA) had issued an